Kidney donation after circulatory death (DCD) is a less than ideal option to meet organ
shortages. Hypothermic machine perfusion (HMP) with Belzer solution (BS) improves the …

Simple Summary In this study, we explore for the first time an innovative tool for organ
preservation aimed to preventing ischemia reperfusion injury (IRI) in marginal kidneys from …

Background: Mesenchymal stromal cells (MSCs) derived extracellular vesicles (EVs) were
regarded as a potent medium for kidney injury repair and angiogenesis were regarded as …

Background/Aims: The therapeutic potential of extracellular vesicles (EVs) derived from
mesenchymal stromal cells (MSCs) in kidney injury has been largely reported. However …

Background The potential of a mesenchymal stem cell (MSC) therapy to accelerate the
repair of ischemically damaged human kidneys during 24 hours of warm perfusion was …

Background The renal endothelium is a prime target for ischemia-reperfusion injury (IRI)
during donation and transplantation procedures. Mesenchymal stromal cells (MSC) have …

Background. Several studies demonstrated that mesenchymal stem cells (MSCs) reverse
acute kidney injury (AKI) by a paracrine mechanism rather than by MSC transdifferentiation …

Extracellular vesicles (EVs) derived from human bone marrow mesenchymal stromal cells
(MSCs) promote the regeneration of kidneys in different animal models of acute kidney …

Novel therapies are urgently needed to address the rising incidence and prevalence of
acute kidney injury (AKI) and chronic kidney disease (CKD). Mesenchymal stem/stromal …

Mesenchymal stromal cells (MSC) have been demonstrated to attenuate renal
ischemia/reperfusion (I/R) damage in rodent models. The mechanisms of such nephro …